Introduction Efficient preventive management of acute exacerbation of chronic obstructive pulmonary disease (COPD) is ...
Among the central risk factors in early-stage oncology investing is the distance separating laboratory findings from clinical reality. Onco-Innovations has worked methodically to close that gap. The ...
Part C domestic enrollment is underway at three clinical sites in the U.S.CHICAGO, June 25, 2026 (GLOBE NEWSWIRE) -- MAIA Biotechnology, Inc.
IAccess Alpha Virtual Best Ideas Summer Investment Conference 2026 June 23, 2026 12:30 PM EDTCompany ParticipantsShaun Bagai - ...
A COVID-19 vaccine study blocked by the CDC's acting director was published in a scientific journal. The study affirmed that ...
Introduction: The prevalence and risk factors for postoperative incisional hernia (IH) following cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy (CRS-HIPEC) remain ...
Soil bacteria make cocktails of molecules that synergistically inhibit the growth of microbial pathogens — suggesting a ...
Recently closed $50 million underwritten offering reinforces strong institutional investor conviction and bolsters balance sheet for execution of second Phase 3 HLP003 trial1- 2,3, EMBRACE, for potent ...
Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and ...
The SUBITO trial, presented by Rianne L Seefat and colleagues in The Lancet Oncology,1 revisits the long-standing debate surrounding high-dose chemotherapy with autologous stem-cell rescue in patients ...
In sum, the student transformed a general interest in children in tragedy to an examination of Euripides’ depictions of children murdered by their parents. They then narrowed their focus to three ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results